Cerenome updates financial calendar

CNSY•2026-11-12

Cerenome will report third-quarter 2026 results on Nov. 16 and hold a conference call at 8:30 a.m. ET to review REYOBIQ ReSPECT-LM data and provide a CNSide commercial update; the data are scheduled for presentation at SNO on Nov. 13.

1. Results and conference call

Cerenome will report third-quarter 2026 financial results on Nov. 16. A conference call that day at 8:30 a.m. ET will review REYOBIQ ReSPECT-LM data and provide a CNSide commercial update. The clinical data are scheduled for presentation at the SNO conference on Nov. 13, 2026.

Cerenome updates financial calendar

1. Results and conference call

Related News

BCP Investment agrees to acquire Investcorp Credit Management BDC

Takeda's Orzeyful available in U.S. by prescription to treat narcolepsy type 1 in adults

Astronics presents 2026 revenue outlook of $1.02 billion to $1.04 billion

American Shared Hospital Services Q3 net loss widens to $620,000; revenue rises 6% to $7.62 million

Athene publishes November 2026 fixed income investor presentation